208 related articles for article (PubMed ID: 11391530)
1. An early lesion in hepatic carcinogenesis: loss of heterozygosity in human cirrhotic livers and dysplastic nodules at the 1p36-p34 region.
Sun M; Eshleman JR; Ferrell LD; Jacobs G; Sudilovsky EC; Tuthill R; Hussein MR; Sudilovsky O
Hepatology; 2001 Jun; 33(6):1415-24. PubMed ID: 11391530
[TBL] [Abstract][Full Text] [Related]
2. Molecular changes in hepatocellular dysplastic nodules on microdissected liver biopsies.
Maggioni M; Coggi G; Cassani B; Bianchi P; Romagnoli S; Mandelli A; Borzio M; Colombo P; Roncalli M
Hepatology; 2000 Nov; 32(5):942-6. PubMed ID: 11050043
[TBL] [Abstract][Full Text] [Related]
3. The expression of transforming growth factor-alpha in cirrhosis, dysplastic nodules, and hepatocellular carcinoma: an immunohistochemical study of 70 cases.
Yeh MM; Larson AM; Campbell JS; Fausto N; Rulyak SJ; Swanson PE
Am J Surg Pathol; 2007 May; 31(5):681-9. PubMed ID: 17460450
[TBL] [Abstract][Full Text] [Related]
4. Clonal analysis of macronodules in cirrhosis.
Paradis V; Laurendeau I; Vidaud M; Bedossa P
Hepatology; 1998 Oct; 28(4):953-8. PubMed ID: 9755231
[TBL] [Abstract][Full Text] [Related]
5. The vascular profile of regenerative and dysplastic nodules of the cirrhotic liver: implications for diagnosis and classification.
Roncalli M; Roz E; Coggi G; Di Rocco MG; Bossi P; Minola E; Gambacorta M; Borzio M
Hepatology; 1999 Nov; 30(5):1174-8. PubMed ID: 10534338
[TBL] [Abstract][Full Text] [Related]
6. Quantitative assessment of hTERT mRNA expression in dysplastic nodules of HBV-related hepatocarcinogenesis.
Oh BK; Kim YJ; Park YN; Choi J; Kim KS; Park C
Am J Gastroenterol; 2006 Apr; 101(4):831-8. PubMed ID: 16494581
[TBL] [Abstract][Full Text] [Related]
7. Early hepatocellular carcinoma and dysplastic nodules.
Kojiro M; Roskams T
Semin Liver Dis; 2005; 25(2):133-42. PubMed ID: 15918142
[TBL] [Abstract][Full Text] [Related]
8. Expression of DNA methyltransferases in multistep hepatocarcinogenesis.
Choi MS; Shim YH; Hwa JY; Lee SK; Ro JY; Kim JS; Yu E
Hum Pathol; 2003 Jan; 34(1):11-7. PubMed ID: 12605361
[TBL] [Abstract][Full Text] [Related]
9. Telomere shortening and telomerase reactivation in dysplastic nodules of human hepatocarcinogenesis.
Oh BK; Jo Chae K; Park C; Kim K; Jung Lee W; Han KH; Nyun Park Y
J Hepatol; 2003 Nov; 39(5):786-92. PubMed ID: 14568262
[TBL] [Abstract][Full Text] [Related]
10. Loss of heterozygosity of chromosome 8p and 11p in the dysplastic nodule and hepatocellular carcinoma.
Kahng YS; Lee YS; Kim BK; Park WS; Lee JY; Kang CS
J Gastroenterol Hepatol; 2003 Apr; 18(4):430-6. PubMed ID: 12653892
[TBL] [Abstract][Full Text] [Related]
11. Alterations of p53, Bcl-2, and hMSH2 protein expression in the cirrhotic, macroregenerative, dysplastic nodules and hepatocellular carcinomas in Upper Egypt.
Hussein MR
Liver Int; 2004 Dec; 24(6):552-60. PubMed ID: 15566504
[TBL] [Abstract][Full Text] [Related]
12. Ductular reaction is helpful in defining early stromal invasion, small hepatocellular carcinomas, and dysplastic nodules.
Park YN; Kojiro M; Di Tommaso L; Dhillon AP; Kondo F; Nakano M; Sakamoto M; Theise ND; Roncalli M
Cancer; 2007 Mar; 109(5):915-23. PubMed ID: 17279586
[TBL] [Abstract][Full Text] [Related]
13. Relationship between loss of heterozygosity at microsatellite loci and computerized nuclear morphometry in hepatocellular carcinoma.
Suzuki K; Hirooka Y; Tsujitani S; Yamane Y; Ikeguchi M; Kaibara N
Anticancer Res; 2000; 20(2B):1257-62. PubMed ID: 10810431
[TBL] [Abstract][Full Text] [Related]
14. Perfusion-weighted MRI in evaluating the intranodular hemodynamic characteristics of dysplastic nodules and hepatocellular carcinomas in an experimental rat model.
Xu H; Xie JX; Li X; Yang ZH; Zheng ZZ; Wang B; Wang Z
J Magn Reson Imaging; 2008 Jan; 27(1):102-9. PubMed ID: 18022847
[TBL] [Abstract][Full Text] [Related]
15. Preneoplastic lesions in human hepatocarcinogenesis.
Libbrecht L; Desmet V; Roskams T
Liver Int; 2005 Feb; 25(1):16-27. PubMed ID: 15698394
[TBL] [Abstract][Full Text] [Related]
16. Multiple genetic alterations, 4q28, a new suppressor region, and potential gender differences in human hepatocellular carcinoma.
Hammond C; Jeffers L; Carr BI; Simon D
Hepatology; 1999 May; 29(5):1479-85. PubMed ID: 10216132
[TBL] [Abstract][Full Text] [Related]
17. Allelic imbalances and homozygous deletion on 8p23.2 for stepwise progression of hepatocarcinogenesis.
Midorikawa Y; Yamamoto S; Tsuji S; Kamimura N; Ishikawa S; Igarashi H; Makuuchi M; Kokudo N; Sugimura H; Aburatani H
Hepatology; 2009 Feb; 49(2):513-22. PubMed ID: 19105209
[TBL] [Abstract][Full Text] [Related]
18. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B virus-associated multistep hepatocarcinogenesis: a stepwise increase in allelic alterations.
Lee JM; Wong CM; Ng IO
Cancer Res; 2008 Jul; 68(14):5988-96. PubMed ID: 18632655
[TBL] [Abstract][Full Text] [Related]
20. Molecular changes from dysplastic nodule to hepatocellular carcinoma through gene expression profiling.
Nam SW; Park JY; Ramasamy A; Shevade S; Islam A; Long PM; Park CK; Park SE; Kim SY; Lee SH; Park WS; Yoo NJ; Liu ET; Miller LD; Lee JY
Hepatology; 2005 Oct; 42(4):809-18. PubMed ID: 16175600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
